PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 9613746-6 1998 Treatment with ACTH was associated with significant correlations between dopaminergic markers such as HVA, dihydroxyphenylacetic acid (DOPAC), and Dopa. 3,4-Dihydroxyphenylacetic Acid 107-133 proopiomelanocortin Homo sapiens 15-19 9613746-6 1998 Treatment with ACTH was associated with significant correlations between dopaminergic markers such as HVA, dihydroxyphenylacetic acid (DOPAC), and Dopa. 3,4-Dihydroxyphenylacetic Acid 135-140 proopiomelanocortin Homo sapiens 15-19 6255276-0 1980 Reduction by beta-endorphin of efflux of dopamine and DOPAC from superfused medial basal hypothalamus. 3,4-Dihydroxyphenylacetic Acid 54-59 proopiomelanocortin Homo sapiens 13-27 6087372-4 1984 The morphine induced increase of striatal DOPAC (3,4-dihydroxyphenylacetic acid) content was also inhibited by ACTH treatment, however, neither the analgesia, nor the hypermotility caused by morphine were affected. 3,4-Dihydroxyphenylacetic Acid 42-47 proopiomelanocortin Homo sapiens 111-115 6087372-4 1984 The morphine induced increase of striatal DOPAC (3,4-dihydroxyphenylacetic acid) content was also inhibited by ACTH treatment, however, neither the analgesia, nor the hypermotility caused by morphine were affected. 3,4-Dihydroxyphenylacetic Acid 49-79 proopiomelanocortin Homo sapiens 111-115 743624-2 1978 The initial injection of beta-endorphin results in increases in the dopamine metabolites, 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA), in neostriatum, as well as increases in the serotonin metabolite, 5-hydroxyindoleacetic acid (5-HIAA), in hypothalamus and brainstem and a decrease in 5-HIAA in hippocampus. 3,4-Dihydroxyphenylacetic Acid 90-120 proopiomelanocortin Homo sapiens 25-39 743624-2 1978 The initial injection of beta-endorphin results in increases in the dopamine metabolites, 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA), in neostriatum, as well as increases in the serotonin metabolite, 5-hydroxyindoleacetic acid (5-HIAA), in hypothalamus and brainstem and a decrease in 5-HIAA in hippocampus. 3,4-Dihydroxyphenylacetic Acid 122-127 proopiomelanocortin Homo sapiens 25-39 567367-1 1978 Acute intracisternal administration of human beta-endorphin produced catalepsy and increased striatal concentrations of 3,4-dihydroxyphenylacetic acid (DOPA) and homovanillic acid (HVA). 3,4-Dihydroxyphenylacetic Acid 120-150 proopiomelanocortin Homo sapiens 45-59 567367-1 1978 Acute intracisternal administration of human beta-endorphin produced catalepsy and increased striatal concentrations of 3,4-dihydroxyphenylacetic acid (DOPA) and homovanillic acid (HVA). 3,4-Dihydroxyphenylacetic Acid 152-156 proopiomelanocortin Homo sapiens 45-59 567367-4 1978 The combination of subcataleptic doses of haloperidol and beta-endorphin produced catalepsy and large increases in striatal DOPAC and HVA. 3,4-Dihydroxyphenylacetic Acid 124-129 proopiomelanocortin Homo sapiens 58-72 905630-1 1977 Acute intraventricular administration of human beta-endorphin increased 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) concentrations in rat striatum at a time when the catatonic effect was also present. 3,4-Dihydroxyphenylacetic Acid 72-102 proopiomelanocortin Homo sapiens 47-61 905630-1 1977 Acute intraventricular administration of human beta-endorphin increased 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) concentrations in rat striatum at a time when the catatonic effect was also present. 3,4-Dihydroxyphenylacetic Acid 104-109 proopiomelanocortin Homo sapiens 47-61